Molecular Oncology
Volume 3, Issue 2 , Pages 165-170, April 2009

Intercepting pelvic cancer in the distal fallopian tube: Theories and realities

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA

Received 21 November 2008; received in revised form 23 January 2009; accepted 26 January 2009. published online 12 February 2009.

Abstract 

The pathogenesis of high-grade serous carcinoma of the ovary has come into sharper focus as closer attention has been paid to the earlier phases of this disease. The study of patients with BRCA mutation has been of particular value, in as much as the examination of prophylactic salpingo-oophorectomies will reveal an early cancer in approximately 5% of individuals. Recently studies have shown that about 80% of these early carcinomas originate in the distal fallopian tube. This review summarizes the recent data supporting the distal fallopian tube as an important site for serous carcinogenesis, stressing both the presence of a novel precursor (the p53 signature) and the application of this model to all women irrespective of BRCA status. The challenges and unmet needs unmasked by this paradigm shift in ovarian cancer research are discussed.

Keywords: Serous carcinoma, Ovarian carcinoma, Intraepithelial carcinoma, p53, BRCA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(09)00020-9

doi:10.1016/j.molonc.2009.01.004

Molecular Oncology
Volume 3, Issue 2 , Pages 165-170, April 2009

Article Tools

* Image Usage & Resolution